FDA Orange Book · active-ingredient family
Cefmetazole sodium
Cefmetazole sodium is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:ZEFAZONE IN PLASTIC CONTAINER · NDA 050683
2
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ZEFAZONE IN PLASTIC CONTAINERRLD×2 | PHARMACIA AND UPJOHN | NDA 050683 | — | Dec 29, 1992 | |
| ZEFAZONERLD×2 | PHARMACIA AND UPJOHN | NDA 050637 | — | Dec 11, 1989 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Cefmetazole sodium — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

